Summary
Lung-tumor cells from pleural effusion of four refractory patients and in cell lines established from them were analyzed for anthracycline retention, cytotoxicity, and MDR-1 gene and P-glycoprotein expression. Murine leukemic P388 and doxorubicin-resistant P388/R84 lines were used as controls. The 50% growth-inhibitory concentration (IC50) for doxorubicin among lung-tumor lines varied from 0.16 to 0.31 μM in soft agar. Heterogeneity in doxorubicin or daunorubicin retention and response to the efflux-blocking action of 25 μm prochlorperazine was noted in pleural effusion of FCCL-1,-4, and-8. Among the cell lines established, an efflux-blocking effect in a subpopulation was noticed only in FCCL-1 and-4. Although the MDR-1 gene was present in all cell lines, including P388, its expression was pronounced only in P388/R84 and FCCL-1. In situ hybridization of antisense RNA probe to tumor cells showed high heterogeneity for MDR-1 message in the human lung-tumor cells as compared with the murine cells. Northern and slot blot hybridization confirmed in situ hybridization in lines with high levels of MDR-1 expression. The synthesis of MDR-1 mRNA and P-glycoprotein in tumor lines was correlated. The results suggest that because of extensive tumor-cell heterogeneity in human tumors, monitoring of MDR expression by in situ hybridization, quantitation of P0glycoprotein content by laser flow cytometry (and/or immunohistochemical methods), and drug efflux (by laser flow cytometry) may be the best ways to monitor multidrug resistance in human tumors.
Similar content being viewed by others
References
Baas F, Jongsma AP, Broxterman HJ, Arceci RJ, Housman D, Scheffer GI, Riethorst A, Groenigen M van, Niewint AWM, Joenje H (1990) Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line. Cancer Res 50: 5392
Bliek AM van der, Baas F, Velde-Koerts T van der, Biedler JL, Meyers MB, Ozols RF, Hamilton JC, Joenje H, Borst P (1988) Genes amplified and overexpressed in human multidrug-resistant cell lines. Cancer Res 48: 5927
Chen C, Chin JE, Ucda K, Pastan I, Gottesman MM, Roninson IB (1986) Internal duplication and homology with bacterial transport proteins in themdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47: 381
Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294
Coley HM, Workman P, Twentyman PR (1990) Retention of activity by selected anthracylines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpression. Br J Cancer 63: 351
Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR (1989) Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86: 695
Cox KH, DeLeon DV, Angerer LM, Angerer RC (1986) Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Dev Biol 101: 485
Croop JM, Guild BC, Gros P, Housman DE (1987) Genetics of multidrug resistance: relationship of a cloned gene to the complete multidrug-resistant phenotype. Cancer Res 47: 5982
Deuchars KL, Du R, Naik M, Evernden-Porelle D, Kartner N (1987) Expression of hamster P-glycoprotein and multidrug resistance in DNA-mediated transformants of mouse LTA cells. Mol Cell Biol 7: 718
Fairchild CR, Ivy SP, Rushmore T (1987) Carcinogen-inducedmdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas. Proc Natl Acad Sci USA 84: 7701
Feinberg AP, Vogelstein B (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 137: 266
Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Roninson IB (1987) Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84: 265
Fuqua SA, Fitzgerald SD, McGuire WLA (1990) Simple polymerase chain reaction method for detection and cloning of low-abundance transcripts. Biotechniques 9: 206
Ganapathi R, Kuo T, Teeter L, Grabowski D, Ford J (1991) Relationship between expression of P-glycoprotein and efficacy of trifluoperazine in multidrug-resistant cells. Mol Pharmacol 39: 1
Gerlach JH, Endicott JA, Juranka PF, Henderson G, Sarangi F, Deuchars KL, Ling V (1986) Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature 324: 485
Goldstein LJ, Galksi H, Fojo AT, Wellingham M, Lai S, Gazdar A, Pirker R, Green A, Crist W, Brodeur G, Grant C, Lieber M, Crossman J, Gottesman MM, Pastan I (1989) Expression of multidrug resistance gene in human cancers. J Natl Cancer Inst 81: 116
Gros P, Croop J, Housman D (1986) Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47: 371
Gros P, Neriah YB, Croop JM, Housman DE (1986) Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 323: 728
Gupta V, Krishan A (1982) Effect of oxygen concentration on the growth and drug sensitivity of human melanoma cells in soft-agar clonogenic assay. Cancer Res 42: 1005
Hait WN, Morris S, Lazo JS, Figlin R-J, Durivage HJ, White K, Schwartz PE (1989) Phase I trial of combined therapy with bleomycin and the calmodulin antagonist, trifluoperazine. Cancer Chemother Pharmacol 23: 358
Harper ME, Marselle LM, Gallo RC, Wong-Staal F (1986) Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc Natl Acad Sci USA 83: 772
Kartner N, Ling V (1989) Multidrug resistance in cancer. Sci Am 260: 44
Keizer HG, Schuurhuis GJ, Broxterman HJ, Lankelma J, Schoonen WGEJ, Rijn J van, Pinedo HM, Joenje H (1989) Correlation of multidrug resistance with decreased drug accumulation, altered subcellular drug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung tumor cells. Cancer Res 49: 2988
Kohno K, Sato S, Takano H, Kato S, Kuwano M (1988) The direct activation of human multidrug resistance gene (MDR-1) by anticancer agents. Biochem Biophys Res Commun 165: 1415
Kohno K, Sato S, Uchiumi T, Takano H, Kato S, Kuwano M (1990) Tissue-specific enhancer of the human multidrug-resistance (MDR1) gene. J Biol Chem 265: 19690
Krishan A, Sridhar KS, Davila E, Vogel C, Sterheim W (1987) Patterns of anthracycline retention modulation in human tumor cells. Cytometry 8: 306
Krishan A, Sauerteig A, Stein JH (1991) Flow cytometric monitoring of P-glycoprotein expression in tumor cells: a comparison of three commercially available antibodies. Cytometry 12: 731
Kuzmich S, Tew KD (1991) Detoxification mechanisms and tumor cell resistance to anticancer drugs. Med Res Rev 11: 185
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680
Lai S, Goldstein LJ, Gottesman MM, Pastan I (1989) MDR1 gene expression in lung cancer. J Natl Cancer Inst 81: 1144
Lawrence JB, Singer RH (1985) Quantitative analysis of in situ hybridization methods for the detection of actin gene expression. Nucleic Acids Res 13: 1777
Lincke CR, Blick AM van der, Schuurhuis GJ, Velde-Koerts T van der, Smith JAM, Borst P (1990) Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human MDR-1 complementary DNA. Cancer Res 50: 1779
Lincke CR, Smit JJ, Velde-Koerts T van der, Borst P (1991) Structure of the human MDR3 gene and physical mapping of the human MDR locus. J Biol Chem 266: 5303
Miller RL, Bukowski RM, Budd GT, Purvis J, Weick JK, Shepard K, Medha KK, Ganapathi R (1988) Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial. J Clin Oncol 6:880
Minna JD, Higgins GA, Glatstein EJ (1985) Cancer of the lung. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, vol 18. J. B. Lippincott, Philadelphia, p 507
Morrow CS, Cowan KH (1988) Mechanisms and clinical significance of multidrug resistance. Oncology 2:55
Moscow JA, Fairchild CR, Madden MJ, Rahsom DT, Wieand HS, O'Brien EE, Poplock DG, Crossman J, Myers CE, Cowan KH (1989) Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res 49:1422
Murphy LD, Herzog CE, Rudick JB, Fojo AT, Bates SE (1990) Use of the polymerase chain reaction in the quantitation ofmdr-1 gene expression. Biochemistry 29:10351
Nair S, Singh SV, Krishan A (1991) Flow cytometric monitoring of glutathione content and anthracyline retention in tumor cells. Cytometry 12:336
Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Hoff DD von, Roninson IB (1990) Quantitative analysis of MDR1 (multidrug-resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87:7160
Ramachandran C, Raghavan V (1990) Intracellular localization of glutelin mRNA during grain development in rice. J Exp Bot 41:393
Raymond M, Rose E, Housman DE, Gros P (1990) Physical mapping, amplification, and overexpression of the mousemdr gene family in multidrug-resistant cells. Mol Cell Biol 10:1642
Roninson IB, Abelson HT, Housman DE, Howell N, Varshavsku A (1984) Amplification of specific DNA sequences correlates with multidrug-resistance in Chinese hamster cells. Nature 309:626
Roninson IB, Chin JE, Choi K, Gros P, Housman DE, Fojo A, Shen DW, Gottesman MM, Pastan I (1986) Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 83:4538
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning — a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
Scotto KW, Biedler JL, Melera PW (1986) Amplification and expression of genes associated with multidrug resistance in mammalian cells. Science 232:751
Shanbaky NM, Samy TSA, Rubin R, Krishan A (1986) Membrane-associated proteins of Adriamycin-sensitive and-resistant murine leukemic P388 cells. Int J Peptide Protein Res 27:414
Shen D, Fojo A, Chin JE, Roninson IB, Rickert N, Pastan I, Gottesman MM (1986) Human multidrug-resistant cell lines: increasedmdr-1 expression can precede gene amplification. Science 232:643
Silverberg E, Lubera J (1987) Cancer statistics. CA 37:2
Slater RJ (1984) The purification of poly (A)-containing RNA by affinity chromatography. In: Walker JM (ed) Methods in molecular biology, vol 2. Humana, Clifton, New Jersey, p 117
Southern EM (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98:503
Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Wellingham MC (1987) Cellular localization of multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84:7735
Ueda K, Pastan I, Gottesman MM (1987) Isolation and sequence of the promoter region of the human multidrug-resistance (P-glycoprotein) gene. J Biol Chem 262:17432
Ueda K, Cardarelli C, Gottesman MM, Pastan I (1987) Expression of a full-length cDNA for human “MDR 1” gene confers resistance to colchicine, doxorubicin and vinblastine. Proc Natl Acad Sci USA 84: 3004
Ueda K, Chen C, Kriegler M, Kriegler M, Roninson IB (1988) An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr 1 (P-glycoprotein) gene. Cell 53:519
Author information
Authors and Affiliations
Additional information
This work was supported by NIH grant CA-R01 44737
Rights and permissions
About this article
Cite this article
Ramachandran, C., Sauerteig, A., Sridhar, K.S. et al. MDR-1 gene expression, anthracycline retention and cytotoxicity in human lung-tumor cells from refractory patients. Cancer Chemother. Pharmacol. 31, 431–441 (1993). https://doi.org/10.1007/BF00685031
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00685031